Skip to Main Content

Paper Details

Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens.
Cancer Res Commun
1
2023
Author NameAffiliation
Philippe L BedardPrincess Margaret Cancer Centre-University Health Network, University of Toronto
  • 1 - 1

Datasets

Release 1.2